The cGMPs merely state to exclude foreign matter and to minimize foreign particle content. The USP can provide further guidance with regard to definitions, methods, and limits for visible and subvisible particles, though. And this does not only apply to sterile injectable products, but also to biotherapeutic and ophthalmic products. Please read more here